Archives for May 29, 2003

← 2003

Advanced Biosciences is new kid on the block

Speciality chemical company Rohm and Haas has created a new business unit, Advanced Biosciences, that specialises in the production and purification of biopharmaceuticals. The new unit is well placed to address the shortfall in production capacity...

Schwarz to slash staff in Ireland

Reports in Ireland have suggested that Germany's Schwarz Pharma is planning to scale back its operations in Shannon and cut its workforce. The company is allegedly planning to reduce its Irish workforce by 70 to around 180 staff.

Acceptys licenses cell line for Ab production

US biopharmaceutical firm Acceptys has licensed an immortal humanised cell line from Columbia University, which will allow it to discover and produce fully human monoclonal antibodies and other human proteins for use as therapeutic products to treat...

Industry group calls for pharma regulation shake-up

The European Federation of Pharmaceutical Industries and Associations has called for the European Commission to set up a more favourable legal framework to help the region's pharmaceutical industry compete with its peers in the USA and elsewhere.

SkyePharma expects revenue surge in 2003

UK company SkyePharma is expecting to achieve turnover of £100 million (€139m) in 2003, which would represent a rise of around 40 per cent over last year. However, the company has warned that the lion's share of this total would come in the second...